Paras Health’s public payors extend its receivable cycle

Paras Health’s reliance on government schemes and public sector undertakings, or PSUs, has extended its receivable cycle. Government schemes and PSUs contributed 43.63% of revenue in the three months ended June 30, 2026, while their average receivable period was 166.69 days, compared with 5.73 days for self-pay patients.

How much does Paras Health depend on public payors?

Paras Health depended on government schemes and PSUs for its largest revenue share in the latest reported quarter. Revenue from this category was Rs 205.21 crore in the three months ended June 30, 2026, representing 43.63% of Rs 470.278 crore in revenue from operations. Its share increased from 38.06% in the three months ended June 30, 2025, when government schemes and PSUs generated Rs 140.225 crore.

The longer comparison also shows a change in Paras Health’s payor mix. Government schemes and PSUs accounted for 41.28% of Fiscal 2026 revenue, compared with 30.91% in Fiscal 2024. Revenue from this category increased to Rs 662.919 crore in Fiscal 2026 from Rs 399.995 crore in Fiscal 2024, while self-pay’s revenue contribution declined to 33.88% from 41.01%.

Self-pay represents healthcare services settled directly by domestic or international patients at or before discharge, without insurance, corporate credit arrangements or government-scheme coverage. Insurance and third-party administrator arrangements cover cashless treatment, including corporate credit arrangements. Government-scheme and PSU revenue represents public healthcare programmes, subsidies and government-department employee welfare schemes that cover treatment for eligible patients.

Why do Paras Health’s public payors extend its receivable cycle?

Paras Health’s public payors extended its receivable cycle because government schemes and PSUs recorded average receivable days of 166.69 in the three months ended June 30, 2026. This was 17.13 days higher than 149.56 days in the three months ended June 30, 2025. In the latest quarter, self-pay receivables averaged 5.73 days and insurance-category receivables averaged 52.95 days.

Government schemes and PSUs also represented a larger share of receivables than of revenue. Gross average trade receivables from this category were Rs 380.075 crore in the three months ended June 30, 2026, or about 83% of Rs 458.798 crore across the three disclosed payor categories. Government-scheme and PSU gross average receivables were Rs 233.03 crore a year earlier, when average receivable days were 149.56.

Paras Health says government schemes and PSUs generally have longer payment cycles because claims can be subject to budgetary constraints, administrative processing, scrutiny, verification requirements, reimbursement audits and delays in claim settlement. The company says these delays can occur across a scheme or system and affect multiple participating healthcare providers. The longer cycle would persist if those reimbursement processes continue to take more time than collections from self-pay and insurance categories.

How far have Paras Health’s receivables and working-capital needs increased?

Paras Health’s net trade receivables increased to Rs 447.60 crore at June 30, 2026 from Rs 267.528 crore at June 30, 2025. Receivables outstanding for more than six months rose to Rs 128.162 crore from Rs 66.167 crore over the same period. Total trade-receivable days increased to 76.28 from 61.34, and Paras Health states that neither quarterly measure was annualised.

The Fiscal 2026 comparison indicates that the overall receivables cycle had already lengthened before the June 2026 quarter. Trade-receivable days were 66.36 in Fiscal 2026, compared with 55.14 in Fiscal 2025 and 46.38 in Fiscal 2024. Paras Health attributes the increase during the last three fiscals primarily to the larger scale of operations and longer payment cycles for credit customers, particularly government schemes and PSUs.

Working-capital requirements, which Paras Health defines as trade receivables plus inventories less trade payables, were Rs 221.461 crore in the three months ended June 30, 2026. This compared with Rs 82.885 crore in the corresponding 2025 period and Rs 173.361 crore in Fiscal 2026. Higher receivables do not establish a collection loss, but they leave cash committed to claims until payments are received.

What could change Paras Health’s collection and funding position?

Paras Health’s collection position could change if reimbursement policies, package rates, claim-settlement mechanisms, eligibility criteria, empanelment conditions or claim-approval processes change under government schemes. Paras Health identifies prolonged or system-wide reimbursement delays as factors that could increase working-capital requirements, reduce cash flows and increase outstanding receivables. The company also says higher health-insurance penetration could reduce self-pay revenue and affect realisation and profitability because insurers have higher negotiating power.

The receivables cycle operates alongside bank-funded working-capital requirements. Paras Health had consolidated borrowings of Rs 939.467 crore outstanding as of August 31, 2026, including Rs 375.978 crore of cash-credit and working-capital demand loans. It also held bank balances other than cash and cash equivalents, including earmarked balances linked to working-capital facilities, of Rs 352.939 crore at June 30, 2026.

Paras Health intends to repay or prepay part of borrowings incurred by the company and one subsidiary from net offer proceeds. The filing also states that existing operations and its business strategy may require substantial capital resources and that Paras Health may incur additional debt. Its ability to fund receivables will therefore depend on both timely claim settlements and access to funding for receivables, inventories and other operating requirements.

Conclusion

Paras Health’s revenue growth has coincided with a changed payor mix, with government schemes and PSUs becoming its largest quarterly revenue category at 43.63% in the three months ended June 30, 2026. This category accounted for about 83% of disclosed gross average receivables and took 166.69 days on average to pay, making it the main disclosed source of working-capital exposure.

The next updates to watch are whether government-scheme and PSU receivable days decline from 166.69, whether balances outstanding for more than six months fall from Rs 128.162 crore, and how the disclosed debt-prepayment plan affects funding requirements. Changes to reimbursement rules, claim approvals or empanelment conditions could also affect the timing and certainty of collections.